Diabetes Bexagliflozine Dapagliflozine IND Dasiglucagon Exenatide IND Finerenon Kerendia is indicated for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults. Extension of indication to include the treatment of chronic kidney disease (CKD) and for the prevention of cardiovascular (CV) events in adults with CKD (regardless of the stage of albuminuria) associated with type 2 diabetes IND Insulin lispro G Polyethylene glycol loxenatide Sotagliflozine IND Teplizumab Tirzepatide Liver diseases Maralixibat IND Obeticholic acid Seladelpar Metabolic diseases Arimoclomol Autologous CD34+ cell enriched population that contains hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral vector encoding the human arylsulfatase A gene Avalglucosidase alfa Bardoxolone Methyl Betaine G Cipaglucosidase alfa / miglustat Elamipretide Fexapotide Fezolinetant Fosdenopterin Hydrocortison Leriglitazone Levoketoconazole Liraglutide IND Lonafarnib Migalastat IND Octreotide Olenasufligene relduparvovec Olipudase alfa Palovarotene Pegunigalsidase alfa Reloxaliase Sapropterin G Somatrogon Sparsentan Other metabolism and Endocrinology Abaloparatide Burosumab IND Corifollitropin alfa IND Drospirenon / estetrol, monohydraat Ospemifene Semaglutide Setmelanotide IND Unknown Dapagliflozine IND Diazoxide choline (controlled-release tablet) Empagliflozine IND Levonorgestrel G Linzagolix Lonapegsomatropin Lumasiran Mirabegron IND Osilodrostat Relugolix IND Relugolix / estradiol / norethisteronen Setmelanotide Sofpironium bromide Vosoritide